MLAB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Mesa Laboratories Inc (MLAB) is not a strong buy for a beginner, long-term investor at this time. While the technical indicators show some bullish momentum, the financial performance is concerning with significant YoY declines in net income and EPS. Additionally, there are no recent positive catalysts or strong trading signals to justify immediate action.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200) and a positive MACD histogram (1.269), indicating upward momentum. However, the RSI_6 at 78.775 is in the neutral zone, suggesting no clear overbought or oversold conditions. Key resistance levels are at R1: 100.047 and R2: 103.503, while support levels are at S1: 88.863 and S2: 85.407.
The company posted a solid beat on Q3 revenue and adjusted EBITDA, with strong margin expansion despite foreign-exchange headwinds. Analysts have raised the price target from $83 to $94.
No recent news or significant trading trends from hedge funds, insiders, or Congress.
In Q3 2026, revenue increased by 3.64% YoY to $65.13M, and gross margin improved to 64.18% (+1.45% YoY). However, net income dropped significantly to $3.63M (-316.59% YoY), and EPS fell to 0.65 (-309.68% YoY).
Wells Fargo raised the price target to $94 from $83 and maintained an Equal Weight rating. The firm acknowledges improved financial metrics but remains cautious about valuation.
